{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:24:22Z","timestamp":1740165862068,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:00:00Z","timestamp":1588809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:00:00Z","timestamp":1588809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s13730-020-00485-7","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T04:52:38Z","timestamp":1588827158000},"page":"347-353","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Rapidly progressive glomerulonephritis caused by tegafur\/gimeracil\/oteracil resulted in diabetes nephropathy, in a patient with minor risk of diabetes nephropathy: a case report"],"prefix":"10.1007","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3712-6331","authenticated-orcid":false,"given":"Naoya","family":"Toriu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Imafuku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiko","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinari","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Yamanouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rikako","family":"Hiramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Hayami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Kawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Suwabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Ubara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,7]]},"reference":[{"key":"485_CR1","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1053\/j.ajkd.2016.10.006","volume":"68","author":"MA Lusco","year":"2016","unstructured":"Lusco MA, Fogo AB, Najafian B, et al. AJKD atlas of renal pathology: thrombotic microangiopathy. Am J Kidney Dis. 2016;68:e33\u2013e34.","journal-title":"Am J Kidney Dis"},{"key":"485_CR2","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1056\/NEJMra1312353","volume":"371","author":"JN George","year":"2014","unstructured":"George JN, Nester CM. Syndromes of thrombotic microangiopathy. New England J Med. 2014;371:654\u201366.","journal-title":"New England J Med"},{"key":"485_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1159\/000500716","volume":"12","author":"N Toriu","year":"2019","unstructured":"Toriu N, Sekine A, Mizuno H, et al. Renal-limited thrombotic microangiopathy due to bevacizumab therapy for metastatic colorectal cancer: a case report. Case Rep Oncol. 2019;12:391\u2013400.","journal-title":"Case Rep Oncol"},{"key":"485_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1470-2045(07)70037-2","volume":"8","author":"C Frangi\u00e9","year":"2007","unstructured":"Frangi\u00e9 C, Lefaucheur C, Medioni J, et al. Renal thrombotic microangiopathy caused by anti-VEGF-antibody treatment for metastatic renal-cell carcinoma. Lancet Oncol. 2007;8:177\u20138.","journal-title":"Lancet Oncol"},{"key":"485_CR5","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","volume":"358","author":"V Eremina","year":"2008","unstructured":"Eremina V, Jefferson JA, Kowalewska J, et al. VEGF inhibition and renal thrombotic microangiopathy. New England J Med. 2008;358:1129\u201336.","journal-title":"New England J Med"},{"key":"485_CR6","doi-asserted-by":"crossref","unstructured":"Hernandez-Arteaga K, Soto-Abraham V, Perez-Navarro M, et al. Thrombotic microangiopathy in patients with diabetic nephropathy is associated with low VEGF expression and end-stage renal disease. Clinical Nephrol 2017.","DOI":"10.5414\/CN109240"},{"key":"485_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nrneph.2010.152","volume":"7","author":"T Nakagawa","year":"2011","unstructured":"Nakagawa T, Tanabe K, Croker BP, et al. Endothelial dysfunction as a potential contributor in diabetic nephropathy. Nature Rev Nephrol. 2011;7:36\u201344.","journal-title":"Nature Rev Nephrol"},{"key":"485_CR8","first-page":"XE01","volume":"10","author":"P Chhetri","year":"2016","unstructured":"Chhetri P, Giri A, Shakya S, et al. Current Development of Anti-Cancer Drug S. J Clin Diagn Res. 2016;10:XE01\u2013XE5.","journal-title":"J Clin Diagn Res"},{"key":"485_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4174\/jkss.2011.81.3.163","volume":"81","author":"SR Lee","year":"2011","unstructured":"Lee SR, Kim HO, Yoo CH. Clinical outcomes of TS-1 chemotherapy for advanced and recurrent gastric cancer. J Korean Surg Soc. 2011;81:163\u20138.","journal-title":"J Korean Surg Soc"},{"key":"485_CR10","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1182\/blood-2014-11-611335","volume":"125","author":"ZL Al-Nouri","year":"2015","unstructured":"Al-Nouri ZL, Reese JA, Terrell DR, et al. Drug-induced thrombotic microangiopathy: a systematic review of published reports. Blood. 2015;125:616\u20138.","journal-title":"Blood"},{"key":"485_CR11","first-page":"439","volume":"31","author":"J Muto","year":"2017","unstructured":"Muto J, Kishimoto H, Kaizuka Y, et al. Thrombotic Microangiopathy Following Chemotherapy with S-1 and Cisplatin in a Patient with Gastric Cancer: A Case Report. vivo (Athens, Greece). 2017;31:439\u201341.","journal-title":"vivo (Athens, Greece)"},{"key":"485_CR12","doi-asserted-by":"publisher","first-page":"143426","DOI":"10.1155\/2014\/143426","volume":"2014","author":"H Izzedine","year":"2014","unstructured":"Izzedine H. Anti-VEGF Cancer Therapy in Nephrology Practice. Int J Nephrol. 2014;2014:143426.","journal-title":"Int J Nephrol"},{"key":"485_CR13","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/S0959-8049(98)00211-1","volume":"34","author":"Y Sakata","year":"1998","unstructured":"Sakata Y, Ohtsu A, Horikoshi N, et al. Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients. Eur J Cancer. 1998;34:1715\u201320.","journal-title":"Eur J Cancer"},{"key":"485_CR14","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1111\/cas.14025","volume":"110","author":"K Goto","year":"2019","unstructured":"Goto K, Fujiwara Y, Isobe T, et al. Pharmacokinetic study of the oral fluorouracil antitumor agent S-1 in patients with impaired renal function. Cancer Sci. 2019;110:1987\u201394.","journal-title":"Cancer Sci"},{"key":"485_CR15","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1007\/BF02063250","volume":"40","author":"F Kobayashi","year":"1995","unstructured":"Kobayashi F, Ikeda T, Sakamoto N, et al. Severe chronic active hepatitis induced by UFTR containing tegafur and uracil. Dig Dis Sci. 1995;40:2434\u20137.","journal-title":"Dig Dis Sci"},{"key":"485_CR16","doi-asserted-by":"publisher","first-page":"398","DOI":"10.2957\/kanzo.47.398","volume":"47","author":"K Matsumaru","year":"2006","unstructured":"Matsumaru K, Ishii K, Wakui N, et al. A case of liver dysfunction without elevation of serum transaminase induced by 5-Fluorouraci (5-FU) administration for colon cancer with liver metastasis. Kanzo. 2006;47:398\u2013404.","journal-title":"Kanzo"},{"key":"485_CR17","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982\u201392.","journal-title":"Am J Kidney Dis"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-020-00485-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-020-00485-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-020-00485-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T23:26:10Z","timestamp":1620343570000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-020-00485-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,7]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["485"],"URL":"https:\/\/doi.org\/10.1007\/s13730-020-00485-7","relation":{},"ISSN":["2192-4449"],"issn-type":[{"type":"electronic","value":"2192-4449"}],"subject":[],"published":{"date-parts":[[2020,5,7]]},"assertion":[{"value":"14 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the authors declare no competing financial interests and no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}